pancreatic-cancer

Documents about pancreatic-cancer

• A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression#875371ClinicalTrials.gov
• Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification#154946bioRxiv / medRxiv
• Progress and challenges in the development of advanced pancreatic cancer organoids.#165699NCBI PubMed Central
• Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions.#218884NCBI PubMed Central
• CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming.#258162NCBI PubMed Central
• p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis#292613OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Gamabufotalin suppresses pancreatic cancer through redox-homeostasis disruption by G6PD downregulation.#305321NCBI PubMed Central
• Pancreatic cancer metastasis is regulated by an eleven amino-acid sequence#317286Europe PMC
• Bioengineering advances in pancreatic cancer organoids for reproducible tumor microenvironment modeling.#334706NCBI PubMed Central
• The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting.#440781NCBI PubMed Central
• From detection to ruling out in pancreatic cancer: a new perspective.#452830NCBI PubMed Central
• Survival rate in patients with pancreatic cancer in Guilan province, Iran.#621025NCBI PubMed Central
• Data Management and Sharing Plan for: Function of IL35+ B cells in pancreatic cancer#649108UNC Dataverse Dataverse OAI Archive
• Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort.#671164NCBI PubMed Central
• Multi-modal digital twin model outperforms conventional biomarker stratification in pancreatic cancer.#678447NCBI PubMed Central
• Data Management and Sharing Plan for: Remote Malnutrition Monitoring After Surgery for Pancreatic Cancer Patients#681053UNC Dataverse Dataverse OAI Archive
• Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy#853462ClinicalTrials.gov
• Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy#873211ClinicalTrials.gov
• Post Marketing Surveillance Study for ONIVYDE® in South Korea#873277ClinicalTrials.gov
• Mesopancreas Study in Pancreatic Cancer#876238ClinicalTrials.gov
• A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors#831021ClinicalTrials.gov
• Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors#854980ClinicalTrials.gov
• Volatiles in Breath and Headspace Analysis - Diagnostic Markers#882366ClinicalTrials.gov
• Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors#832589ClinicalTrials.gov
• Safety Study of MGD009 in B7-H3-expressing Tumors#894828ClinicalTrials.gov
• Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors#836847ClinicalTrials.gov
• Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors#840319ClinicalTrials.gov
• Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers#909155ClinicalTrials.gov
• Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers#901658ClinicalTrials.gov
• Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis#28401ClinicalTrials.gov
• The Genetic Education for Men Trial: Web-Based Education vs. Standard Care#828286ClinicalTrials.gov
• Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers#842057ClinicalTrials.gov
• Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life#884925ClinicalTrials.gov
• Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1#910648ClinicalTrials.gov
• Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy#812056ClinicalTrials.gov
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma#812744ClinicalTrials.gov
• Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC#843734ClinicalTrials.gov
• A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer#845860ClinicalTrials.gov
• Pancreatic cancer diagnosis on unenhanced CT with deep learning for opportunistic diagnosis.#67476NCBI PubMed Central
• Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy.#135801NCBI PubMed Central
• Dietary Fat Content Influences PanIN Progression and Pancreatic Cancer Development in Mice.#157002NCBI PubMed Central
• Real-world efficacy of nanoliposomal irinotecan in patients with advanced pancreatic cancer#159283HAL (France)
• Characterization of a Transesophageal Focused Ultrasound Transducer for Endoscopic Pancreatic Cancer Ablation#276792OSF
• <b>Computed Tomography Imaging</b>#300602Figshare
• Identifying Cell State Vulnerabilities in Pancreatic Cancer#347595Harvard DASH
• Field-enhanced graphene fiber arrays reveal serum metabolic alterations in pancreatic cancer.#457420NCBI PubMed Central
• Development and Validation of a Parsimonious Risk Stratification Model for Pancreatic Cancer.#476813NCBI PubMed Central
• Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis.#685685NCBI PubMed Central
• Early Palliative Care on Quality of Life of Advanced Cancer Patients#811391ClinicalTrials.gov
• AOH1996 for the Treatment of Refractory Solid Tumors#872103ClinicalTrials.gov